Edition:
United States

Ironwood Pharmaceuticals Inc (IRWD.O)

IRWD.O on Nasdaq

11.50USD
18 Jun 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$11.50
Open
--
Day's High
--
Day's Low
--
Volume
2
Avg. Vol
1,454,643
52-wk High
$21.20
52-wk Low
$9.07

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 68.73 -0.383
FY 2018 Dec '18 130.69 -0.101
Sep '18 65.69 -1.138
Jun '18 81.11 -0.325
Mar '18 69.15 -0.286
FY 2017 Dec '17 94.21 0.080
Sep '17 86.82 -0.216
Jun '17 65.08 -0.297
Mar '17 52.17 -0.355
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 8 89.04 92.22 85.40 99.65
Quarter Ending Sep-19 8 97.82 102.54 89.00 126.37
Year Ending Dec-19 10 373.83 381.68 368.51 434.47
Year Ending Dec-20 10 417.06 471.32 383.00 503.02
Earnings (per share)
Quarter Ending Jun-19 7 -0.03 0.06 -0.19 -0.20
Quarter Ending Sep-19 7 0.06 0.16 -0.07 0.07
Year Ending Dec-19 5 -0.04 0.21 -0.40 -0.08
Year Ending Dec-20 6 0.50 0.63 0.20 0.50
LT Growth Rate (%) 1 73.10 73.10 73.10 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 104.93 37.25
P/E High - Last 5 Yrs. -- 162.20 57.61
P/E Low - Last 5 Yrs. -- 51.16 28.59
Beta 1.73 1.20 0.96
Price to Sales (TTM) 5.17 42.66 10.17
Price to Book (MRQ) -- 12.57 4.51
Price to Tangible Book (MRQ) -- 18.45 5.33
Price to Cash Flow (TTM) -- 69.22 25.96
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.10 1.63
Dividend Yield - 5 Year Avg -- 0.05 1.34
Dividend 5 Year Growth Rate -- 0.77 6.50
Payout Ratio(TTM) -- 1.46 37.70

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -0.61 59.87 15.39
Sales (TTM) vs TTM 1 Yr. Ago 9.82 45.94 8.68
Sales - 5 Yr. Growth Rate 72.22 33.23 10.38
EPS (MRQ) vs Qtr. 1 Yr. Ago -33.91 -8.61 18.74
EPS (TTM) vs TTM 1 Yr. Ago -170.59 -- --
EPS - 5 Yr. Growth Rate -- 22.03 7.13
Capital Spending - 5 Yr. Growth Rate -2.11 24.55 7.95

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.70 2.74 2.47
Current Ratio (MRQ) 1.70 3.75 3.43
LT Debt to Equity (MRQ) -- 7.71 14.10
Total Debt to Equity (MRQ) -- 21.10 19.80
Interest Coverage (TTM) -2.08 35.75 15.44

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 90.99 27.34 50.03
Gross Margin - 5 Yr. Avg. 93.07 59.67 51.24
EBITD Margin (TTM) -22.64 -- --
EBITD - 5 Yr. Avg -34.00 -7.64 16.16
Operating Margin (TTM) -74.35 -107.66 -7.96
Operating Margin - 5 Yr. Avg. -56.04 -24.07 11.42
Pre-Tax Margin (TTM) -86.22 -108.84 -8.43
Pre-Tax Margin - 5 Yr. Avg. -71.04 -29.64 16.18
Net Profit Margin (TTM) -86.22 -114.47 -12.23
Net Profit Margin - 5 Yr. Avg. -71.04 -35.00 11.35
Effective Tax Rate (TTM) -- 17.23 20.14
Effective Tax Rate - 5 Yr. Avg. -- 18.84 24.32

Efficiency

  Company industry sector
Revenue/Employee (TTM) 672,260 8,319,575 784,041,417
Net Income/Employee (TTM) -579,627 1,738,124 91,870,420
Receivable Turnover (TTM) 4.83 10.98 5.82
Inventory Turnover (TTM) 27.14 2.42 3.68
Asset Turnover (TTM) 0.74 0.33 0.81

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -63.88 6.34 9.69
Return on Assets - 5 Yr. Avg. -31.65 6.24 10.67
Return on Investment (TTM) -79.21 7.73 12.15
Return on Investment - 5 Yr. Avg. -37.05 8.17 13.58
Return on Equity (TTM) -- 8.25 16.99
Return on Equity - 5 Yr. Avg. -448.92 9.18 15.11
  1 Year 3 Year 5 Year
Sales % 16.21 32.34 72.22
EPS (TTM) % -135.71 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Ironwood Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -0.09 -1.92 99 98
13 Week 0.80 -2.14 99 72
26 Week 25.47 9.49 99 33
52 Week -25.85 -29.51 99 9
YTD 32.62 13.94 99 19
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 228
Total Shares Held: 163,574,322
3 Mo. Net Change: 5,952,316
# New Positions: 40
# Closed Positions: 27
# Increased Positions: 110
# Reduced Positions: 88
# Net Buyers: 22
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.